Skip to main content

Table 3 Enriched pathways by target mRNAs of the 20-lncRNA list

From: An ensemble of the iCluster method to analyze longitudinal lncRNA expression data for psoriasis patients

ID

Description

Observed gene count

Background gene count

False discovery rate

GO: cellular component

 GO:0005839

Proteasome core complex

7

21

<0.0001

 GO:0019773

Proteasome core complex, alpha-subunit complex

6

8

<0.0001

 GO:0000796

Condensin complex

5

7

<0.0001

 GO:0000799

Nuclear condensin complex

2

3

0.0033

 GO:1904813

Ficolin-1-rich granule lumen

4

125

0.0213

 GO:0043232

Intracellular non-membrane-bounded organelle

24

4005

0.0302

 GO:0044444

Cytoplasmic part

43

9377

0.0302

 GO:0000932

P-body

3

81

0.0475

 GO:0005737

Cytoplasm

48

11238

0.0475

GO: molecular function

 GO:0004298

Threonine-type endopeptidase activity

7

21

<0.0001

 GO:0005031

Tumor necrosis factor-activated receptor activity

3

25

0.0092

 GO:0070011

Peptidase activity, acting on l-amino acid peptides

8

603

0.0362

GO: biological process

 GO:0007076

Mitotic chromosome condensation

5

15

<0.0001

 GO:0010032

Meiotic chromosome condensation

4

5

<0.0001

 GO:0016579

Protein deubiquitination

7

275

0.0099

 GO:0006323

DNA packaging

6

195

0.0111

 GO:0043687

Post-translational protein modification

7

365

0.0253

KEGG pathway

 hsa03050

Proteasome

7

43

<0.0001